It arises in the hematopoietic stem cell and is characterized by the presence of BCR-ABL fusion gene as a result of translocation between chromosomes t(9,22) (q34; q11.2). CML affects bone marrow and peripheral blood [3]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.